A Study of the Efficacy and Safety of Alteplase in Participants With Mild Stroke
Clinical trial NCT02072226 · TERMINATED
Trial details
- NCT number
- NCT02072226
- Sponsor
- Genentech, Inc.
- Status
- TERMINATED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2014-05-31
- Primary completion
- 2017-03-22
- Enrollment
- 313
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.